These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 42096

  • 1. [Occurrence of tardive extrapyramidal symptoms in schizophrenic patients undergoing prolonged neuroleptic treatment].
    Rybakowski J, Jaracz J, Lis B, Milewska G, Lezańska M.
    Psychiatr Pol; 1979; 13(5):479-85. PubMed ID: 42096
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE.
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
    Ezrin-Waters C, Seeman MV, Seeman P.
    J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
    [Abstract] [Full Text] [Related]

  • 9. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T, Furuya M, Yasuda H, Hayashida M, Nishida A, Inagaki T, Horiguchi J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):761-4. PubMed ID: 18201810
    [Abstract] [Full Text] [Related]

  • 10. Tardive dyskinesia in chronic schizophrenic inpatients.
    Kua EH, Ang PC, Siew HC.
    Singapore Med J; 1982 Feb 01; 23(1):19-21. PubMed ID: 6126008
    [No Abstract] [Full Text] [Related]

  • 11. [Testing basic visual functions in the evaluation of extrapyramidal side effects of antipsychotic agents].
    Kéri S, Antal A, Szekeres G, Szendi I, Kovács Z, Janka Z, Benedek G.
    Orv Hetil; 1998 Feb 01; 139(5):235-8. PubMed ID: 9489377
    [Abstract] [Full Text] [Related]

  • 12. Neuroleptic-induced tardive dyskinesia.
    Jenner P, Marsden CD.
    Acta Psychiatr Belg; 1987 Feb 01; 87(5):566-98. PubMed ID: 2897761
    [Abstract] [Full Text] [Related]

  • 13. Amisulpride-induced tardive dyskinesia.
    Fountoulakis KN, Panagiotidis P, Siamouli M, Kantartzis S, Mavridis T, Iacovides A, Kaprinis G.
    Schizophr Res; 2006 Dec 01; 88(1-3):232-4. PubMed ID: 16963229
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical and epidemiologic aspects of tardive dyskinesia.
    Baldessarini RJ.
    J Clin Psychiatry; 1985 Apr 01; 46(4 Pt 2):8-13. PubMed ID: 2858483
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients.
    Chouinard G, Annable L, Ross-Chouinard A.
    Psychopharmacol Bull; 1986 Apr 01; 22(3):891-6. PubMed ID: 2879310
    [No Abstract] [Full Text] [Related]

  • 19. Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.
    Waddington JL, Youssef HA, Molloy AG, O'Boyle KM, Pugh MT.
    J Clin Psychiatry; 1985 Apr 01; 46(4 Pt 2):29-33. PubMed ID: 2858476
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.